XLS |
Net sales, operating result (EBIT) and research and development costs, by business sector |
||||||||||
|
|
|
|
|
||||||
€ million |
Healthcare |
Life Science |
Performance Materials |
Group1 |
||||||
|
||||||||||
|
|
|
|
|
||||||
2015 |
|
|
|
|
||||||
Net sales |
6,934 |
3,355 |
2,556 |
12,845 |
||||||
Operating result (EBIT) |
1,097 |
301 |
878 |
1,843 |
||||||
R&D costs |
1,310 |
197 |
197 |
1,709 |
||||||
|
|
|
|
|
||||||
2016 |
|
|
|
|
||||||
Net sales |
6,855 |
5,658 |
2,511 |
15,024 |
||||||
Operating result (EBIT) |
1,593 |
556 |
823 |
2,481 |
||||||
R&D costs |
1,496 |
260 |
213 |
1,976 |